Bromocriptine Mesilate

溴隐亭甲磺酸盐

Report date: 2024/02/21 14:40:51
NME

Base Information

Drug NameBromocriptine Mesilate
Drug Alias NameBromocriptin-Richter溴隐停甲磺酸溴隐亭Bromocriptine-QR甲黄酸溴麦角环肽 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsFeeding BehaviorOverweightObesity +[12] 
Global Approved IndicationsInfertilityHyperprolactinemiaParkinson Disease +[4] 
Approved Indications in ChinaInfertilityHyperprolactinemiaAcromegaly
Original Approved Country/TerritoryUnited States
Original Approved Date1978/06/28
Country/TerritoryCanadaUnited StatesGermany +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesU.S. Pharmaceuticals Holdings I
China Registration ClassN/A

Develop Information

Active CompaniesEsjay Pharma LLCKyoto UniversityVeroscience Llc +[5] 
Inactive CompaniesHannover Medical SchoolMylan Pharmaceuticals IncJiangsu Hansoh Pharmaceutical Group Co Ltd +[6] 
Active IndicationsDiabetes Mellitus, Type 2Cardiomyopathy, DilatedInfertility +[7] 
Inactive IndicationsFeeding BehaviorOverweightObesity +[5] 

Other Information

ATC CodeG02CB01N04BC01
Related LinksWikipediaDrugBankKEGG